Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

Regulatory approved apps gain worldwide momentum, reveals GlobalData

Regulatory approved apps, classified as medical devices, are a rapidly emerging segment of digital health, having strong double-digit growth. The adoption of these apps is rising across many regions and therapeutic areas, signalling a strong push towards digitally monitored healthcare models, says GlobalData, a leading data and analytics company. Regulatory approved apps are broadly classified […]
Read more

Data centers turn to oceans and space amid surging AI-driven energy demand, says GlobalData

The growing popularity of artificial intelligence (AI), cloud services, and digital applications is driving unprecedented demand for computing power, placing huge pressure on traditional land-based data centers. To alleviate some of this pressure and meet the needs of increasingly complex AI workloads, alternative environments must be explored. Oceans and space offer abundant cooling, energy, and […]
Read more

Philippines card payments set to grow 18.8% in 2025, forecasts GlobalData

The Philippines’ card payments market is projected to grow by 18.8% in 2025 to reach PHP4.2 trillion ($72 billion), supported by sustained financial inclusion efforts and improving acquiring infrastructure, according to GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that the total card payment value in the Philippines grew by 20.5% […]
Read more

India MRI systems market to grow at 12% CAGR between 2025 and 2035, forecasts GlobalData

India’s medical imaging landscape is entering a phase of accelerated transformation, driven by the integration of artificial intelligence (AI), augmented reality (AR), and machine learning (ML) into magnetic resonance imaging (MRI) workflows. In this context, India’s MRI systems market is projected to expand at a compound annual growth rate (CAGR) of nearly 12% between 2025 […]
Read more

Singapore expands precision imaging capacity with new Molecular Imaging and Theranostics Centre, says GlobalData

Singapore has expanded its national capabilities in molecular imaging and translational research with the establishment of the Molecular Imaging and Theranostics Centre, a joint initiative by the National University Hospital (NUH) and the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine). It is expected to strengthen Singapore’s leadership in […]
Read more

SASE and SD-WAN changes accelerate as enterprises prioritize unified networking and security, says GlobalData

The shifting of software-defined wide area network (SD-WAN to secure access service edge (SASE) and) is reshaping enterprise connectivity strategies. This is driven by hybrid work, cloud migration, and rising security challenges that demand simplified, end-to-end architectures, according to GlobalData, a leading data and analytics company. Over the past decade, SD-WAN transformed enterprise routing by […]
Read more

FDA signals strong regulatory push for precision oncology as ADC review designations hit record high in 2024, says GlobalData

The FDA is accelerating its support for precision cancer therapies, awarding a record 63 review designations to antibody drug conjugates (ADCs) in 2024, nearly double the previous year’s peak of 35. This sharp rise underscores the agency’s strengthened intent to speed market access for high-value oncology innovations and reflects surging confidence in ADC technology, according […]
Read more

International Diabetes Day highlights urgent need for early detection and equitable care, says GlobalData

Rising global diabetes rates are intensifying calls for earlier detection and fairer access to care, signalling how health systems must evolve to manage escalating clinical and economic pressures. This year’s International Diabetes Day on 14 November spotlights persistent treatment gaps, the expanding role of technology-enabled monitoring, and the policy action needed to prevent complications and […]
Read more

GLP-1 evidence signals shift in future dialysis care in US, says GlobalData

Emerging evidence that GLP-1 therapies can slow chronic kidney disease (CKD) progression is reshaping expectations for renal care demand in the US. As semaglutide demonstrates measurable reductions in kidney decline, cardiovascular events, and mortality, clinicians and device manufacturers face a pivotal inflection point, balancing delayed disease progression with the likelihood of more patients ultimately surviving […]
Read more

Two in five FS organizations got involved with cryptos in H1, showing growing confidence in digital currencies technology, says GlobalData

20% of financial services (FS) industry insiders reported having cryptos as part of their organizations’ core operation in a sentiment poll* conducted globally across GlobalData’s FS news media sites during the first half (H1) of 2025. An additional 20% are expected to follow suit, either having implementation plans in place (6%), or looking into strategies […]
Read more

Coca-Cola ad campaigns shift from personal refreshment to collective connection, reveals GlobalData

The Coca-Cola Company has undergone a notable transformation in its advertising themes and focus areas between Q2 (April to June) and Q3 (July to September) of 2025. The latest analyses reveal a strategic pivot from individualistic messaging centered around personal breaks and revitalization to a more community-centric approach that emphasizes togetherness, cultural relevance, and shared […]
Read more

US tariff and pricing reforms drive pharma localization and spur outsourcing-led investment shifts, says GlobalData

Escalating US tariff and pricing reforms are pushing pharmaceutical companies to localize manufacturing and rethink their investment priorities, fueling a surge in outsourcing-led strategies and targeted acquisitions. The recent deals in obesity and liver disease, Pfizer’s purchase of Metsera and Roche’s acquisition of 89bio, underscore how dealmaking is increasingly shaped by policy incentives, tariff exposure, […]
Read more

High-value VC investments concentrate within top 10 markets in Q1-Q3 2025 as US extends dominance, reveals GlobalData

High-value* venture capital (VC) activity during the first three quarters (Q1-Q3) of 2025 remained overwhelmingly clustered within the world’s top 10 investment markets, with the US extending its dominance across both deal volume and value. The sharp concentration of mega-deals signals a maturing late-stage funding landscape, where capital increasingly flows toward established ecosystems, reshaping competitive […]
Read more

Sovato Series B signals rising confidence in remote-capable surgical robotics, says GlobalData

Remote-enabled surgical robotics is entering a pivotal growth phase as next-generation platforms integrate teleoperation, advanced imaging, and high-speed connectivity to expand clinical reach. Sovato’s latest Series B financing reinforces this momentum, reflecting rising investor confidence in digitally integrated systems that enhance access, precision, and workflow efficiency, signalling a broader shift toward robotics technologies poised to […]
Read more
1 … 18 19 20 21 22 … 209